Stockhub

SanBio Company Limited: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

22 September 2022

  • curprev 19:4719:47, 22 September 2022 95.149.241.133 talk 785 bytes +785 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == SanBio Company Limited develops, produces, and sells regenerative cell medicines for the central nervous system. The company develops SB623 that has completed a phase 2 clinical trial to treat traumatic brain injury in the United States and Japan. Its research pipeline products also comprise SB623 for ischemic and hemorrhagic strokes, age-related macular degeneration, retinitis pigments, spinal cord injury, Parkinson's dise..."
Retrieved from "https://stockhub.co/research/SanBio_Company_Limited"